Isolation, identification and antimicrobial susceptibility testing of Haemophilus influenzae | CMAC

Isolation, identification and antimicrobial susceptibility testing of Haemophilus influenzae

Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(2):93-109

Section
Guidelines
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(2):93-109

Abstract

These guidelines are focused on the one of the most frequent bacterial pathogen causing community-acquired infections – Haemophilus influenzae. Collection of clinical specimens, selective and non-selective media for isolation, morphological and phenotypic approaches to identification are described in details. Advantages and disadvantages of different susceptibility testing methods are highlighted. Criteria for interpretation of results based on international guidelines (NCCLS) are presented. These guidelines are designed for microbiologists, epidemiologists, and laboratory assistants.

  • 1. Haemophilus. In : Koneman E.W., Allen S.D., Janda W.M., Schreckenberger P.C., Winn W.C., editors. Color Atlas and Textbook of Diagnostic Microbiology. 5th ed. Lippincott: Philadelphia;1997. p.363-94.
  • 2. Pittman M. Variation and type specificity in the bacterial species Haemophilus influenzae. J Exp Med 1931; 53:471-92.
  • 3. Kiehn T.E., Verhoef J. Haemophilus spp. In: Armstrong D., Cohen J., editors. Infectious diseases. Harcourt Publishers Ltd; 1999. p.8-20.7-20.11.
  • 4. Spinola S.M., Peacock J., Denny F.W., et al. Epidemiology of colonization with nontypable Haemophilus influenzae in children: A longitudinal study. J infect Dis 1986; 154:100-9.
  • 5. Harabuchi Y., Faden H., Yamanaka N., et al. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. J Infect Dis 1994; 170: 862-6.
  • 6. Murphy T.F. Haemophilus. In: Gorbach S.L., Bartlett J.G., Blacklow N.R., editors. Infectious Diseases. 2nd ed. W.B. Saunders Company; 1998. p. 1845-58.
  • 7. Orenstein W., Wharton M., Bart K.J., Hinman A.R. Immunization. In: Mandell G.L., Bennett J.E., Dolin R., editors. Principles and practice of infectious diseases. 5th ed. Churchill Livingstone; 2000. p. 3213-4.
  • 8. Campos J.M. Haemophilus spp. In: Murrey P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.M., editors. Manual of Clinical Microbiology. 7th ed. ASM Press; 1999. p.604-13.
  • 9. Felmingham D., Washington J. Trends in antimicrobial susceptibility of bacterial respiratory tract pathogens – findings of the Alexander project 1992-1996. J Chemother 1999; 11:5-21.
  • 10. Jacoby G.A. Prevalence and resistance mechanisms of common bacterial respiratory pathogens. Clin Infect Dis 1994;18:951-7.
  • 11. Fuchs P.C., Barry A.L. Interpretative criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin and amoxicillin/clavulanate. J Clin Microbiol 1994; 32:2846-50.
  • 12. Crokaert F., Aoun M., Duchateau V. Are macrolides active against Haemophilus influenzae? Are the in vitro tests reliable? Proceedings of the 35th ICAAC, San Francisco, 1995.
  • 13. Acar J. Resistance patterns of Haemophilus influenzae. J Chemother 1999; 11:44-50.
  • 14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; ninth informational supplement. NCCLS Document M100-S9 1999;19(1).
  • 15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 5th ed. NCCLS Document M7-A5 2000;20(2).
  • 16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; tenth informational supplement. NCCLS Document M100-S10(M7) 2000.
  • 17. Leitch C., Boonlayangoor S. b-Lactamase test. In: Isenberg H.D. Clinical microbiology procedures handbook. ASM; 1992. p.5.3.1.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared